ESC Professional Premium Access

The effect of sildenafil on maternal mortality in pulmonary arterial hypertension associated with congenital heart disease

Congress Presentation

About the speaker

Mrs Nabila Sabri Nahdi

Sardjito hospital, Yogyakarta (Indonesia)
0 follower

7 more presentations in this session

Effect of a short course of parenteral treprostinil therapy on right heart structure and function in pulmonary arterial hypertension

Speaker: Doctor C. Vizza (Rome, IT)

Thumbnail

Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study

Speaker: Doctor M. Pentikainen (Helsinki, FI)

Thumbnail

Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE

Speaker: Professor P. Jansa (Prague, CZ)

Thumbnail

Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension

Speaker: Doctor G. martini (Bologna, IT)

Thumbnail

Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.

Speaker: Doctor A. Mamzer (Lodz, PL)

Thumbnail

Access the full session

Current treatment of pulmonary hypertension: it is all about vasodilators

Speakers: Mrs N. Nahdi, Doctor C. Vizza, Doctor M. Pentikainen, Professor P. Jansa, Doctor G. martini...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations